Company news
All things Automata-related, from investment, press releases to important hiring news.
February 22, 2022
Automata raises US$50 Million in Series B financing to accelerate automation in life sciences
January 30, 2023
bit.bio partners with Automata to automate a key aspect of its production of iPSC derived human cells
February 13, 2023
Automata partners with The Francis Crick Institute on integrated automation for genomics
July 18, 2023
Automata partners with The Royal Marsden to increase cancer genomic testing capacity through robotic automation
October 3, 2023
$40m fundraise backed by Dimension and A.P. Moller Holding, to expand growing life science lab automation offering
November 6, 2023
Joe Stringer appointed Executive Chairman and Director of Corporate Development (EMEA)
November 6, 2023
Automata Executive Chairman and Director of Corporate Development (EMEA) Joe Stringer on why he’s joining Automata
February 9, 2024
Health Services Laboratories unlocks faster turnaround times for NHS pathology services by collaborating with Automata
March 7, 2024
Winner in the Product: Medicine/Health category
April 25, 2024
Automata Technologies appoints advisory board of senior health and life sciences industry executives
June 11, 2024
UK’s first robotic genomic testing facility for cancer patients launches
June 13, 2024
Automata Technologies achieves ISO 9001 certification
September 9, 2024
Leading US research center, Duncan Neurological Research Institute, partners with Automata to automate studies of human brain cell models
